News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research Yael L. Maxwell February 22, 2017
News Daily News Coronary Calcium IDs Higher Heart Disease Risk Even in Younger Adults Todd Neale February 10, 2017
News Daily News Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint Michael O'Riordan February 03, 2017
News Daily News FH Screening Started at Time of Childhood Immunization Feasible and Effective Michael O'Riordan October 28, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Daily News Despite War and Strife, Ischemic Heart Disease Leads Deaths in ‘Arab Spring’ Michael O'Riordan August 26, 2016
News Daily News Depression Increases Risk of Acute MI by 30% in HIV-Positive Patients L.A. McKeown August 25, 2016
News Daily News Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients Michael O'Riordan August 16, 2016
News Daily News MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer Michael H. Wilson July 13, 2016
News Daily News Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology Yael L. Maxwell June 24, 2016
News Daily News Se Observan Descensos en las Hospitalizaciones por IAM y Mortalidad en Distintos Niveles de Ingresos Aunque se Mantienen las Disparidades Todd Neale May 16, 2016
News Daily News Reductions in Acute MI Hospitalization, Mortality Seen Across Income Levels, but Disparities Linger Todd Neale May 16, 2016
News Daily News Low BMI in and of Itself Portends Poor Survival After Acute MI Caitlin E. Cox April 21, 2016
News Daily News Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV Michael O'Riordan January 26, 2016
News Daily News Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis Michael O'Riordan January 26, 2016